Press Release: Prominent Participation of the I.D. Stem Cells and Genome Institute at the 5th Global Regenerative Congress in Budva
The 5th Global Regenerative Congress kicked off in Budva, Montenegro, from December 6th to 8th,
attracting a wide range of researchers and specialists in regenerative medicine and stem cell therapy. The I.D. Stem Cells and Genome Institute had a distinguished presence at this global event by presenting groundbreaking research and engaging in important scientific discussions.
Today, Dr. Amina Dababseh presented a research paper titled "A New Approach in the Management of Perimenopausal Menstrual Disorders", which garnered significant attention from fellow researchers. The study focused on utilizing stem cells as a novel and promising method for managing menstrual disorders during perimenopause. The initial results of this approach have shown promising outcomes, opening new horizons for therapeutic solutions in the treatment of infertility and menstrual disorders through advanced stem cell technologies. This research underscores the importance of innovation in regenerative medicine and highlights the potential for achieving significant progress in treating such common and complex medical conditions.
In addition, Professor Islam Dababseh, Director of the Institute, held several key scientific meetings with fellow researchers from various countries. These discussions centered around the advanced research and treatments being developed by the I.D. Medical Group, both through research conducted within the institute and the treatments offered at I.D. Clinic in Ukraine, as well as at the group's affiliated centers in various countries. The meetings emphasized the importance of strengthening international collaboration in regenerative medicine and exchanging expertise to achieve tangible results that benefit patients globally.
These conferences serve as vital platforms for showcasing the latest advancements in stem cell research and regenerative medicine, as well as an opportunity to strengthen ties with specialists from around the world. At the I.D. Stem Cells and Genome Institute, we are committed to continuing the development of innovative therapeutic techniques that contribute to improving the quality of life for patients worldwide.
Stay tuned for more updates on our participation in this global congress and the latest findings from our pioneering research in regenerative medicine.
